Entero Therapeutics (ENTO) Stock Chart & Stock Price History $0.48 -0.05 (-10.21%) Closing price 03/28/2025 03:57 PM EasternExtended Trading$0.48 -0.01 (-1.12%) As of 03/28/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Entero Therapeutics Stock Price Performance 5 Day Performance-13.11%1 Month Performance-2.89%3 Month Performance-22.52%6 Month Performance+39.49%Year-To-Date Performance-22.77% Receive ENTO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Entero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address ENTO Stock Chart for Sunday, March, 30, 2025 ENTO Chart by TradingViewRemove Ads Entero Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/28/2025$0.54$0.48-10.21%$0.57$0.4877,221 shs$2.28 million03/27/2025$0.58$0.54-7.60%$0.57$0.5328,783 shs$2.54 million03/26/2025$0.55$0.58+4.72%$0.58$0.5044,634 shs$2.75 million03/25/2025$0.60$0.55-7.60%$0.58$0.5534,934 shs$2.63 million03/24/2025$0.61$0.60-1.25%$0.60$0.52119,421 shs$2.85 million03/21/2025$0.53$0.61+15.43%$0.61$0.50109,987 shs$2.88 million03/20/2025$0.53$0.53-0.76%$0.53$0.4926,368 shs$2.50 million03/19/2025$0.55$0.53-3.80%$0.55$0.5126,833 shs$2.52 million03/18/2025$0.53$0.55+3.17%$0.56$0.4979,637 shs$2.61 million03/17/2025$0.48$0.53+10.58%$0.56$0.48105,052 shs$2.53 million Get the Latest News and Ratings for ENTO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/14/2025$0.47$0.48+2.12%$0.54$0.4747,318 shs$2.29 million03/13/2025$0.50$0.47-5.37%$0.50$0.4621,674 shs$2.24 million03/12/2025$0.48$0.50+4.57%$0.50$0.4359,677 shs$2.37 million03/11/2025$0.48$0.48-0.65%$0.51$0.45207,072 shs$2.27 million03/10/2025$0.55$0.48-12.82%$0.55$0.4880,345 shs$2.28 million03/07/2025$0.56$0.55-1.66%$0.62$0.52143,841 shs$2.62 million03/06/2025$0.56$0.56-0.85%$0.64$0.50386,385 shs$2.66 million03/05/2025$0.51$0.56+10.98%$0.58$0.48172,673 shs$2.69 million03/04/2025$0.61$0.51-16.57%$0.61$0.49580,825 shs$2.42 million03/03/2025$0.49$0.61+23.31%$0.90$0.559.21 million shs$2.90 million02/28/2025$0.48$0.49+2.63%$0.49$0.479,762 shs$2.35 million Related Companies Indaptus Therapeutics Stock Chart Silexion Therapeutics Stock Chart Gelteq Stock Chart Apollomics Stock Chart Neuphoria Therapeutics Inc. - Common Stock Stock Chart Traws Pharma Stock Chart Relmada Therapeutics Stock Chart AIM ImmunoTech Stock Chart Acurx Pharmaceuticals Stock Chart Turnstone Biologics Stock Chart Receive ENTO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Entero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENTO) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | SponsoredTrump… a socialist? Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entero Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entero Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ENTO Stock Free ENTO Stock Alerts